The new policy, aimed at propelling advancements in biotechnology, comes more than two decades after the state s initial foray into the sector with the introduction of the Biotech Policy in 2001, , biotechnology, biotech, Siddharamaiah, karnataka, policy, kiran mazumdar shaw, AVGC-XR
Despite the global challenges of high interest rates and geopolitical uncertainties, the economy remains resilient, buoyed by rising domestic demand and sectoral recovery. The outlook for H2 FY2023 and FY2024 looks positive, suggesting a resurgence in deals as market valuations stabilise. The financial health of the Indian companies is underscored by data from S&P Global Ratings, which projects a remarkable 50% increase in EBITDA by FY2024, while debt levels remain stable. This reflects a positive outlook for the corporate sector, demonstrating the strength of India s economy in the face of global adversity.